FLSM
Frazier Life Sciences Management’s HilleVax HLVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.1M | Hold |
10,617,062
| – | – | 0.84% | 25 |
|
|
2025
Q1 | $15.4M | Hold |
10,617,062
| – | – | 0.7% | 29 |
|
|
2024
Q4 | $22M | Hold |
10,617,062
| – | – | 0.91% | 24 |
|
|
2024
Q3 | $18.7M | Hold |
10,617,062
| – | – | 0.75% | 29 |
|
|
2024
Q2 | $154M | Buy |
10,617,062
+835,590
| +9% | +$12.1M | 7.18% | 4 |
|
|
2024
Q1 | $163M | Hold |
9,781,472
| – | – | 6.86% | 4 |
|
|
2023
Q4 | $157M | Hold |
9,781,472
| – | – | 8.39% | 2 |
|
|
2023
Q3 | $132M | Hold |
9,781,472
| – | – | 8.74% | 2 |
|
|
2023
Q2 | $168M | Hold |
9,781,472
| – | – | 10.04% | 1 |
|
|
2023
Q1 | $162M | Buy |
9,781,472
+23,113
| +0.2% | +$382K | 11.71% | 1 |
|
|
2022
Q4 | $163M | Hold |
9,758,359
| – | – | 10.15% | 1 |
|
|
2022
Q3 | $167M | Buy |
9,758,359
+472,677
| +5% | +$8.08M | 12.84% | 1 |
|
|
2022
Q2 | $101M | Buy |
+9,285,682
| New | +$101M | 9.58% | 2 |
|